Peter Weinstein
Chief Executive Officer Circurna
Seminars
Wednesday 11th November 2026
Exploring an Optimized Circular RNA Platform to Treat a Multitude of Diseases
8:30 am
- Developing an iterative and AI-optimized circular RNA platform that results in robust protein expression and a manufacturing process that provides high purity and high yield at a low cost
- Showcasing microneedle technology resulting in high protein production and therapeutic response
- Outlining how circular RNA therapeutics have shown outstanding efficacy and are considerably better than a comparable linear mRNA
